earnings
confidence high
sentiment positive
materiality 0.70
Twist Bioscience Q1 FY2022: revenue $42M (+49% YoY), orders up 48%, raises FY guidance
Twist Bioscience Corp
2023-Q1 EPS reported
-$0.91
revenue$42,018,000
- Revenue of $42.0M (up 49% from $28.2M YoY); orders of $49.6M (up 48% from $33.6M).
- Net loss $45.6M ($0.91 per share) vs $32.9M ($0.72 per share) in prior year.
- Cash, cash equivalents and investments $408.7M as of Dec 31, 2021; shipped to ~1,800 customers.
- Raised fiscal 2022 revenue guidance; specific numbers not provided in the press release excerpt.